A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

NCT06044077 ·Status: RECRUITING ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

NCT02573181 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

NCT06177912 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

NCT05569954 ·Status: COMPLETED ·Phase: PHASE3

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

NCT05731115 ·Status: COMPLETED ·Phase: PHASE4

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

NCT06531538 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)

NCT04168190 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

NCT03512288 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

NCT00327522 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)

NCT05464420 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

NCT05420961 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)

NCT00496093 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of a Single Dose of Pneumococcal Whole-Cell Vaccine in Healthy Adults

NCT07059182 ·Status: COMPLETED ·Phase: PHASE1

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

NCT01444352 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

NCT07086677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

NCT04875533 ·Status: COMPLETED ·Phase: PHASE3

A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant

NCT07023081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

NCT03547167 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

NCT04989465 ·Status: COMPLETED ·Phase: PHASE4

Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine

NCT04087460 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)

NCT05425732 ·Status: COMPLETED ·Phase: PHASE3

Phase I to Test a New Pneumococcal Vaccine

NCT03303976 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

NCT00307528 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

NCT05489328 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

NCT00744263 ·Status: COMPLETED ·Phase: PHASE4